The most recent issue of the Alimentary Pharmacology & Therapeutics evalautes microbiome changes associated with sustained eradication of Clostridium difficile after single fecal microbiota transplantation in children with and without inflammatory bowel disease.
The most recent issue of the Alimentary Pharmacology & Therapeutics evaluates whether endotoxemia is associated with NAFLD in the general population, and studied dietary factors associated with endotoxemia.
September's publication of the Alimentary Pharmacology & Therapeutics investigated the effects of portal pressure on virological responses in hepatitis C patients treated with interferon-free regimens.
A study in the latest issue of the American Journal of Gastroenterology evaluates the prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population.
A study published in September's issue of the Alimentary Pharmacology & Therapeutics compares vonoprazan, a novel potassium-competitive acid blocker, with lansoprazole for the treatment of erosive esophagitis.
This month's American Journal of Gastroenterology evaluates the cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease.